Cart
sales@molnova.com
MHY-1685
CAS No. 27406-31-1
MHY-1685( 5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione )
Catalog No. M28290 CAS No. 27406-31-1
MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 25MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMHY-1685
-
NoteResearch use only, not for human use.
-
Brief DescriptionMHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
-
DescriptionMHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
-
In Vitro——
-
In Vivo——
-
Synonyms5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number27406-31-1
-
Formula Weight232.195
-
Molecular FormulaC11H8N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (269.18 mM)
-
SMILESOc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sánchez-Hernández E, et al. Physicochemical Characterization and Antimicrobial Activity against Erwinia amylovora, Erwinia vitivora, and Diplodia seriata of a Light Purple Hibiscus syriacus L. Cultivar. Plants (Basel). 2021 Sep 10;10(9):1876.
molnova catalog
related products
-
PI3K/Akt/mTOR-IN-2
PI3K/Akt/mTOR-IN-2 is a potent PI3K/AKT/mTOR inhibitor with anticancer effects and selectivity for MDA-MB-231 cells (IC50 2.29 μM). It induces cell cycle arrest and apoptosis in cancer cells.
-
CZC-25146
CZC-25146 is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively.
-
SPI--112Me
SPI--112Me
